z-logo
Premium
Regional metabolic changes in Parkinsonian patients with normal dopaminergic imaging
Author(s) -
Eckert Thomas,
Feigin Andrew,
Lewis Daniel E.,
Dhawan Vijay,
Frucht Steven,
Eidelberg David
Publication year - 2006
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.21185
Subject(s) - parkinson's disease , dopaminergic , positron emission tomography , medicine , nuclear medicine , cohort , neuroimaging , central nervous system disease , neuroprotection , levodopa , magnetic resonance imaging , radiology , disease , dopamine , psychiatry
Dopaminergic imaging has been found to be normal in approximately 15% of parkinsonian patients enrolled in neuroprotective trials. We used 18 F‐fluorodeoxyglucose positron emission tomography (FDG PET) to determine the metabolic basis for this finding. We reviewed scans from 185 patients with clinical signs of Parkinson's disease (PD) who underwent 18 F‐fluorodopa PET imaging for diagnostic confirmation. Of this group, 27 patients (14.6%) had quantitatively normal scans; 8 of these patients were additionally scanned with FDG PET. Pattern analysis was performed on an individual scan basis to determine whether the metabolic changes were consistent with classic PD. Computer‐assisted single‐case assessments of the FDG PET scans of these 8 patients did not disclose patterns of regional metabolic change compatible with classical PD or an atypical parkinsonian variant. Similarly, network quantification revealed that PD‐related pattern expression was not elevated in these patients as it was in an age‐ and duration‐matched cohort with classical PD ( P < 0.0001). None of these patients developed clinical signs of classical PD or of an atypical parkinsonian syndrome at a follow‐up visit conducted 3 years after imaging. The results suggest that parkinsonian subjects with normal dopaminergic imaging do not have evidence of classical PD or an atypical parkinsonian syndrome. © 2006 Movement Disorder Society

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here